CA1337971C - Products and processes for increasing the growth rate and /or utilization of feeds or foods and/or resistance in animals and humans - Google Patents
Products and processes for increasing the growth rate and /or utilization of feeds or foods and/or resistance in animals and humansInfo
- Publication number
- CA1337971C CA1337971C CA000579451A CA579451A CA1337971C CA 1337971 C CA1337971 C CA 1337971C CA 000579451 A CA000579451 A CA 000579451A CA 579451 A CA579451 A CA 579451A CA 1337971 C CA1337971 C CA 1337971C
- Authority
- CA
- Canada
- Prior art keywords
- antigen
- animal
- commercial package
- group
- use according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 241001465754 Metazoa Species 0.000 title claims abstract description 65
- 235000013305 food Nutrition 0.000 title claims abstract description 26
- 238000000034 method Methods 0.000 title abstract description 8
- 230000008569 process Effects 0.000 title abstract description 7
- 239000000427 antigen Substances 0.000 claims abstract description 63
- 102000036639 antigens Human genes 0.000 claims abstract description 63
- 108091007433 antigens Proteins 0.000 claims abstract description 63
- 230000003053 immunization Effects 0.000 claims abstract description 20
- 238000002649 immunization Methods 0.000 claims abstract description 18
- 230000002496 gastric effect Effects 0.000 claims abstract description 8
- 102000004169 proteins and genes Human genes 0.000 claims description 17
- 108090000623 proteins and genes Proteins 0.000 claims description 17
- -1 proteids Chemical class 0.000 claims description 16
- 102000007544 Whey Proteins Human genes 0.000 claims description 11
- 108010046377 Whey Proteins Proteins 0.000 claims description 11
- 230000037396 body weight Effects 0.000 claims description 11
- 239000005862 Whey Substances 0.000 claims description 10
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 10
- 230000001900 immune effect Effects 0.000 claims description 6
- 230000000890 antigenic effect Effects 0.000 claims description 5
- 229920000642 polymer Polymers 0.000 claims description 5
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 5
- 230000004936 stimulating effect Effects 0.000 claims description 5
- LOTKRQAVGJMPNV-UHFFFAOYSA-N 1-fluoro-2,4-dinitrobenzene Chemical compound [O-][N+](=O)C1=CC=C(F)C([N+]([O-])=O)=C1 LOTKRQAVGJMPNV-UHFFFAOYSA-N 0.000 claims description 4
- JYJIMEQNTHFXMT-UHFFFAOYSA-N 2-nitro-2-phenylacetic acid Chemical compound OC(=O)C([N+]([O-])=O)C1=CC=CC=C1 JYJIMEQNTHFXMT-UHFFFAOYSA-N 0.000 claims description 4
- 108010088751 Albumins Proteins 0.000 claims description 4
- 102000009027 Albumins Human genes 0.000 claims description 4
- 102000014914 Carrier Proteins Human genes 0.000 claims description 4
- 108010078791 Carrier Proteins Proteins 0.000 claims description 4
- 102000018832 Cytochromes Human genes 0.000 claims description 4
- 108010052832 Cytochromes Proteins 0.000 claims description 4
- 108010044091 Globulins Proteins 0.000 claims description 4
- 102000006395 Globulins Human genes 0.000 claims description 4
- 229920002527 Glycogen Polymers 0.000 claims description 4
- 229930186217 Glycolipid Natural products 0.000 claims description 4
- 102000003886 Glycoproteins Human genes 0.000 claims description 4
- 108090000288 Glycoproteins Proteins 0.000 claims description 4
- 102000006947 Histones Human genes 0.000 claims description 4
- 108010033040 Histones Proteins 0.000 claims description 4
- 102000004895 Lipoproteins Human genes 0.000 claims description 4
- 108090001030 Lipoproteins Proteins 0.000 claims description 4
- 229930186185 Polyprenol Natural products 0.000 claims description 4
- 229920001731 Polyprenol Polymers 0.000 claims description 4
- 229920005603 alternating copolymer Polymers 0.000 claims description 4
- 150000001413 amino acids Chemical class 0.000 claims description 4
- 229930183167 cerebroside Natural products 0.000 claims description 4
- 150000001784 cerebrosides Chemical class 0.000 claims description 4
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 4
- 229930195729 fatty acid Natural products 0.000 claims description 4
- 239000000194 fatty acid Substances 0.000 claims description 4
- 150000004665 fatty acids Chemical class 0.000 claims description 4
- 102000034240 fibrous proteins Human genes 0.000 claims description 4
- 108091005899 fibrous proteins Proteins 0.000 claims description 4
- 150000002270 gangliosides Chemical class 0.000 claims description 4
- 102000034238 globular proteins Human genes 0.000 claims description 4
- 108091005896 globular proteins Proteins 0.000 claims description 4
- 229940096919 glycogen Drugs 0.000 claims description 4
- 229930182470 glycoside Natural products 0.000 claims description 4
- 150000002338 glycosides Chemical class 0.000 claims description 4
- 229920000578 graft copolymer Polymers 0.000 claims description 4
- 230000028993 immune response Effects 0.000 claims description 4
- 238000002347 injection Methods 0.000 claims description 4
- 239000007924 injection Substances 0.000 claims description 4
- 150000002632 lipids Chemical class 0.000 claims description 4
- 244000005700 microbiome Species 0.000 claims description 4
- 150000002772 monosaccharides Chemical class 0.000 claims description 4
- 102000039446 nucleic acids Human genes 0.000 claims description 4
- 108020004707 nucleic acids Proteins 0.000 claims description 4
- 150000007523 nucleic acids Chemical class 0.000 claims description 4
- 239000002777 nucleoside Substances 0.000 claims description 4
- 125000003835 nucleoside group Chemical group 0.000 claims description 4
- 239000002773 nucleotide Substances 0.000 claims description 4
- 125000003729 nucleotide group Chemical group 0.000 claims description 4
- 229920001542 oligosaccharide Polymers 0.000 claims description 4
- 150000002482 oligosaccharides Chemical class 0.000 claims description 4
- 150000003904 phospholipids Chemical class 0.000 claims description 4
- 150000003096 polyprenols Chemical class 0.000 claims description 4
- 150000004032 porphyrins Chemical class 0.000 claims description 4
- 229920006301 statistical copolymer Polymers 0.000 claims description 4
- 150000003431 steroids Chemical class 0.000 claims description 4
- 230000001925 catabolic effect Effects 0.000 claims description 3
- 229920001519 homopolymer Polymers 0.000 claims description 3
- 230000002503 metabolic effect Effects 0.000 claims description 3
- 238000007911 parenteral administration Methods 0.000 claims description 2
- 150000004676 glycans Chemical class 0.000 claims 1
- 229920001282 polysaccharide Polymers 0.000 claims 1
- 239000005017 polysaccharide Substances 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 abstract description 6
- 230000003308 immunostimulating effect Effects 0.000 abstract 1
- 238000002474 experimental method Methods 0.000 description 15
- 235000018102 proteins Nutrition 0.000 description 14
- 102400000921 Gastrin Human genes 0.000 description 11
- 108010052343 Gastrins Proteins 0.000 description 11
- AOXOCDRNSPFDPE-UKEONUMOSA-N chembl413654 Chemical compound C([C@H](C(=O)NCC(=O)N[C@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@H](CCSC)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC=1C=CC=CC=1)C(N)=O)NC(=O)[C@@H](C)NC(=O)[C@@H](CCC(O)=O)NC(=O)[C@@H](CCC(O)=O)NC(=O)[C@@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H]1N(CCC1)C(=O)CNC(=O)[C@@H](N)CCC(O)=O)C1=CC=C(O)C=C1 AOXOCDRNSPFDPE-UKEONUMOSA-N 0.000 description 11
- 230000000638 stimulation Effects 0.000 description 10
- 241000282472 Canis lupus familiaris Species 0.000 description 8
- 210000002784 stomach Anatomy 0.000 description 8
- 239000000126 substance Substances 0.000 description 8
- 108010086019 Secretin Proteins 0.000 description 7
- 102100037505 Secretin Human genes 0.000 description 7
- 230000029087 digestion Effects 0.000 description 7
- 229960002101 secretin Drugs 0.000 description 7
- OWMZNFCDEHGFEP-NFBCVYDUSA-N secretin human Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(N)=O)[C@@H](C)O)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)C1=CC=CC=C1 OWMZNFCDEHGFEP-NFBCVYDUSA-N 0.000 description 7
- 235000021051 daily weight gain Nutrition 0.000 description 5
- 229940088597 hormone Drugs 0.000 description 5
- 239000005556 hormone Substances 0.000 description 5
- 208000015181 infectious disease Diseases 0.000 description 5
- 230000028327 secretion Effects 0.000 description 5
- 241000282412 Homo Species 0.000 description 4
- 206010070834 Sensitisation Diseases 0.000 description 4
- 230000001079 digestive effect Effects 0.000 description 4
- 239000003651 drinking water Substances 0.000 description 4
- 235000020188 drinking water Nutrition 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 230000007233 immunological mechanism Effects 0.000 description 4
- 238000011835 investigation Methods 0.000 description 4
- 230000008313 sensitization Effects 0.000 description 4
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 3
- 241000700159 Rattus Species 0.000 description 3
- 241000282887 Suidae Species 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 229940098773 bovine serum albumin Drugs 0.000 description 3
- 230000002183 duodenal effect Effects 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 235000013372 meat Nutrition 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 210000004877 mucosa Anatomy 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000014171 Milk Proteins Human genes 0.000 description 2
- 108010011756 Milk Proteins Proteins 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 230000009858 acid secretion Effects 0.000 description 2
- 238000010171 animal model Methods 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 229940088598 enzyme Drugs 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- 230000003054 hormonal effect Effects 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- 235000021239 milk protein Nutrition 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- VGGGPCQERPFHOB-UHFFFAOYSA-N Bestatin Natural products CC(C)CC(C(O)=O)NC(=O)C(O)C(N)CC1=CC=CC=C1 VGGGPCQERPFHOB-UHFFFAOYSA-N 0.000 description 1
- 241000282465 Canis Species 0.000 description 1
- 101800001982 Cholecystokinin Proteins 0.000 description 1
- 102100025841 Cholecystokinin Human genes 0.000 description 1
- 229930105110 Cyclosporin A Natural products 0.000 description 1
- 108010036949 Cyclosporine Proteins 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 208000007514 Herpes zoster Diseases 0.000 description 1
- 108091006905 Human Serum Albumin Proteins 0.000 description 1
- 102000008100 Human Serum Albumin Human genes 0.000 description 1
- 206010061598 Immunodeficiency Diseases 0.000 description 1
- 208000029462 Immunodeficiency disease Diseases 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- 208000015914 Non-Hodgkin lymphomas Diseases 0.000 description 1
- 102000057297 Pepsin A Human genes 0.000 description 1
- 108090000284 Pepsin A Proteins 0.000 description 1
- 241000282898 Sus scrofa Species 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 230000001195 anabolic effect Effects 0.000 description 1
- 239000003674 animal food additive Substances 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 210000003719 b-lymphocyte Anatomy 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 208000003362 bronchogenic carcinoma Diseases 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229940107137 cholecystokinin Drugs 0.000 description 1
- 229960001265 ciclosporin Drugs 0.000 description 1
- 239000000306 component Substances 0.000 description 1
- 229930182912 cyclosporin Natural products 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000010339 dilation Effects 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 239000005428 food component Substances 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 108010074605 gamma-Globulins Proteins 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 206010017758 gastric cancer Diseases 0.000 description 1
- 208000010749 gastric carcinoma Diseases 0.000 description 1
- 210000001156 gastric mucosa Anatomy 0.000 description 1
- 230000007661 gastrointestinal function Effects 0.000 description 1
- 210000005095 gastrointestinal system Anatomy 0.000 description 1
- 235000021472 generally recognized as safe Nutrition 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 244000144993 groups of animals Species 0.000 description 1
- 208000002672 hepatitis B Diseases 0.000 description 1
- 230000008105 immune reaction Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000007813 immunodeficiency Effects 0.000 description 1
- 239000003022 immunostimulating agent Substances 0.000 description 1
- 230000001506 immunosuppresive effect Effects 0.000 description 1
- 239000003018 immunosuppressive agent Substances 0.000 description 1
- 229940125721 immunosuppressive agent Drugs 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000003455 independent Effects 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 229940047124 interferons Drugs 0.000 description 1
- 208000028774 intestinal disease Diseases 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000002751 lymph Anatomy 0.000 description 1
- 230000001926 lymphatic effect Effects 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 201000001441 melanoma Diseases 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 235000013379 molasses Nutrition 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 210000000822 natural killer cell Anatomy 0.000 description 1
- 230000001272 neurogenic effect Effects 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 229940111202 pepsin Drugs 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 235000004252 protein component Nutrition 0.000 description 1
- 239000012460 protein solution Substances 0.000 description 1
- 210000001187 pylorus Anatomy 0.000 description 1
- 230000000384 rearing effect Effects 0.000 description 1
- 230000008261 resistance mechanism Effects 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 230000004202 respiratory function Effects 0.000 description 1
- 235000015067 sauces Nutrition 0.000 description 1
- 208000037921 secondary disease Diseases 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- IZTQOLKUZKXIRV-YRVFCXMDSA-N sincalide Chemical compound C([C@@H](C(=O)N[C@@H](CCSC)C(=O)NCC(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(N)=O)NC(=O)[C@@H](N)CC(O)=O)C1=CC=C(OS(O)(=O)=O)C=C1 IZTQOLKUZKXIRV-YRVFCXMDSA-N 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 201000000498 stomach carcinoma Diseases 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 239000000724 thymus hormone Substances 0.000 description 1
- 230000001960 triggered effect Effects 0.000 description 1
- 229950009811 ubenimex Drugs 0.000 description 1
- 210000001186 vagus nerve Anatomy 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 235000021119 whey protein Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Polymers & Plastics (AREA)
- Microbiology (AREA)
- Animal Husbandry (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Birds (AREA)
- Fodder In General (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19873733899 DE3733899A1 (de) | 1987-10-07 | 1987-10-07 | Erzeugnisse und verfahren zur steigerung von wachstumsgeschwindigkeit und/oder nutzung von futter- oder nahrungsmitteln und/oder resistenz bei tieren und menschen |
| DEP3733899 | 1987-10-07 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA1337971C true CA1337971C (en) | 1996-01-23 |
Family
ID=6337810
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA000579451A Expired - Fee Related CA1337971C (en) | 1987-10-07 | 1988-10-06 | Products and processes for increasing the growth rate and /or utilization of feeds or foods and/or resistance in animals and humans |
Country Status (2)
| Country | Link |
|---|---|
| CA (1) | CA1337971C (en, 2012) |
| DE (1) | DE3733899A1 (en, 2012) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3712890A1 (de) * | 1987-04-15 | 1988-10-27 | Teichmann Reinhard K Priv Doz | Verwendung antigener substanzen zur prophylaxe oder therapie von stoerungen und krankheiten im verdauungstrakt von tieren und menschen |
| DE3733899A1 (de) * | 1987-10-07 | 1989-06-15 | Teichmann Reinhard Prof Dr Med | Erzeugnisse und verfahren zur steigerung von wachstumsgeschwindigkeit und/oder nutzung von futter- oder nahrungsmitteln und/oder resistenz bei tieren und menschen |
| US6027735A (en) * | 1992-07-28 | 2000-02-22 | Effem Gmbh | Products and processes for gastric cascade and gastrointestinal disorder treatment with same |
| JPH11171783A (ja) * | 1997-08-15 | 1999-06-29 | Vetoquinol Sa | 所定の動物に関して細胞性免疫と体重増加を生じる濃度でのバクテリアの経口投与 |
| DE10104055A1 (de) * | 2001-01-31 | 2002-08-14 | Suedzucker Ag | Verwendung von Kohlenhydraten zur Beseitigung von Darminfektionen bei Tieren |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL7009654A (en, 2012) * | 1970-06-30 | 1972-01-03 | ||
| DE2825619A1 (de) * | 1977-06-22 | 1979-01-11 | Sandoz Ag | Vakzinen gegen ferkel-colibacillose und verfahren zu ihrer herstellung |
| FR2408351A1 (fr) * | 1977-11-14 | 1979-06-08 | Unilever Nv | Procede et composition destines a la lutte contre la coccidiose chez la volaille |
| DE3261734D1 (en) * | 1981-03-03 | 1985-02-14 | Centraal Diergeneeskundig Inst | Water-in-oil emulsion for use in the potentation of the immune system of animals |
| DE3712890A1 (de) * | 1987-04-15 | 1988-10-27 | Teichmann Reinhard K Priv Doz | Verwendung antigener substanzen zur prophylaxe oder therapie von stoerungen und krankheiten im verdauungstrakt von tieren und menschen |
| DE3733899A1 (de) * | 1987-10-07 | 1989-06-15 | Teichmann Reinhard Prof Dr Med | Erzeugnisse und verfahren zur steigerung von wachstumsgeschwindigkeit und/oder nutzung von futter- oder nahrungsmitteln und/oder resistenz bei tieren und menschen |
-
1987
- 1987-10-07 DE DE19873733899 patent/DE3733899A1/de active Granted
-
1988
- 1988-10-06 CA CA000579451A patent/CA1337971C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| DE3733899C2 (en, 2012) | 1993-07-01 |
| DE3733899A1 (de) | 1989-06-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Burrin et al. | Porcine colostrum and milk stimulate visceral organ and skeletal muscle protein synthesis in neonatal piglets | |
| Berseth et al. | Comparison of the gastrointestinal growth-promoting effects of rat colostrum and mature milk in newborn rats in vivo | |
| WO2002047612A2 (en) | Dietary supplement compositions | |
| KR20050004223A (ko) | 균활성제 및 경구 내성 | |
| PT2348890E (pt) | Probióticos para utilização em fêmeas de mamíferos gestantes para reforçar a imunidade da sua descendência | |
| US20090311333A1 (en) | Feed or food product composition | |
| AU684824B2 (en) | Use of antigenic substances for the prophylaxis or therapy of disorders and diseases within the gastrointestinal tract of animals and humans | |
| CA1337971C (en) | Products and processes for increasing the growth rate and /or utilization of feeds or foods and/or resistance in animals and humans | |
| Sangild | Transitions in the life of the gut at birth | |
| Telemo et al. | Maternal dietary antigens and the immune response in the offspring of the guinea-pig | |
| JP2849671B2 (ja) | 動物又はヒトにおいて成長率及び／又は飼料又は食物の利用及び／又は抵抗性を増加させる製品及びその方法 | |
| WO2002038146A1 (fr) | Immunomodulateur mucosal et son utilisation | |
| US7045149B2 (en) | Ruminal fluid inoculation of calves | |
| US5725861A (en) | Products and processes for gastric cascade and gastrointestinal disorder treatment with same | |
| Makarova et al. | The use of immunostimulants for the animal diseases prevention | |
| US6027735A (en) | Products and processes for gastric cascade and gastrointestinal disorder treatment with same | |
| CN105454695A (zh) | 一种用于防治猪腹泻的饲料添加剂 | |
| RU2292874C1 (ru) | Способ профилактики диареи у телят | |
| Menge et al. | Nutritional studies with the early weaned neonatal pig | |
| Li et al. | Transient hypersensitivity to soybean meal in the early-weaned pig | |
| Tolman | Soya antigens and anti-soya-antibody formation in calves | |
| Dobbinson | A critical review of the costs of the immune response in high productivity pig systems | |
| Steinshamn et al. | SEAWEED AS A SUPPLEMENT TO RUMINANTS WINTER DIET–LESSONS LEARNED | |
| Roth | Basic Immunology and Principles of Vaccination | |
| Sangild | 1 Transitions in the Life of the |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MKLA | Lapsed |